Tumor Board Review
Springer Publishing Co Inc (Verlag)
978-0-8261-4597-0 (ISBN)
Now in its 3rd edition, Tumor Board Review: Evidence-Based Case Reviews and Questions is the most comprehensive clinical case review book in the field. With hands-on input from current fellows and oncologists, this new edition has been enhanced and reformatted for greater efficiency and practicality.
The review covers all disease-site areas in oncology and features a wide variety of board-style questions pivotal in helping fellows and oncologists prepare for both the ABIM medical oncology board exam and maintenance of certification (MOC) assessments. Evidence-based discussions of difficult patient cases offer an in-depth and accurate depiction of what is discussed at tumor boards and foster critical thinking essential for clinical practice. Patient cases also highlight impactful treatment decisions that include newly approved immunotherapies and targeted therapies. Each chapter contains digestible essentials for each case, including a summary of diagnosis, molecular and genomic testing, treatment options, toxicity considerations, follow-up, and survivorship. Each chapter ends with high-yield multiple-choice questions including answers and detailed rationales ensuring readers are well-equipped with the knowledge they need to make well-informed, individualized treatment decisions. Tumor Board Review: Evidence-Based Case Review and Questions is an essential case-based reference for anyone working in oncology.
Key Features:
Describes more than 120 patient cases, including locally advanced and metastatic cases for each major disease site
Contains 300 board-style questions and answers related to case reviews
Includes new advances in diagnosis and therapy, with a greater emphasis on immunotherapies, cancer genomics, and precision-based targeted therapies
Provides essentials for toxicity considerations, follow-up, and survivorship considerations
Francis P. Worden, MD is a Professor of Medicine and Director of the Hematology/Oncology Fellowship Program at the University of Michigan Medical School in Ann Arbor, Michigan. Martha Pritchett Mims, MD PhD is Professor and Chief of Hematology-Oncology at Baylor College of Medicine in Houston, Texas. Helen K. Chew, MD is Professor of Medicine, Director of the Clinical Breast Cancer Program, and Director of the Hematology Oncology Fellowship Program at University of California Davis in Davis, California.
List of Contributors
Preface
Chapter 1. Head and Neck Cancer
Chapter 2. Thyroid Cancer
Chapter 3. Non-Small Cell Lung Cancer
Chapter 4. Small Cell Lung Cancer
Chapter 5. Hormone Receptor Positive Breast Cancer
Chapter 6. Triple Negative Breast Cancer
Chapter 7. Esophageal Cancer
Chapter 8. Gastric Cancer
Chapter 9. Pancreatic Cancer
Chapter 10. Neuroendocrine Cancer
Chapter 11. Hepatobiliary Cancer
Chapter 12. Colorectal Cancer
Chapter 13. Anal Cancer
Chapter 14. Prostate Cancer
Chapter 15. Testicular Cancer
Chapter 16. Renal Cancer
Chapter 17. Bladder Cancer
Chapter 18. Cervical Cancer
Chapter 19. Uterine Cancer
Chapter 20. Ovarian Cancer
Chapter 21. Melanoma
Chapter 22. Bone Sarcoma
Chapter 23. Soft Tissue Sarcoma
Chapter 24. Primary Brain Tumors
Chapter 25. Cancer Unknown Primary
Chapter 26. Hodgkin Lymphoma
Chapter 27. Non-Hodgkin Lymphoma
Chapter 28. Multiple Myeloma and Plasma Cell Neoplasms
Chapter 29. Acute Lymphoblastic Leukemia
Chapter 30. Acute Myelogenous Leukemia
Chapter 31. Chronic Myeloid Leukemia
Chapter 32. Chronic Lymphocytic Leukemia
Chapter 33. Myelodysplastic Syndrome
| Erscheinungsdatum | 31.08.2022 |
|---|---|
| Zusatzinfo | 40 Illustrations |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 178 x 254 mm |
| Gewicht | 1002 g |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Chirurgie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| ISBN-10 | 0-8261-4597-3 / 0826145973 |
| ISBN-13 | 978-0-8261-4597-0 / 9780826145970 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
